What is a major application of genetically engineered organisms?

What is a major application of genetically engineered organisms?

• A. Enhancing biodiversity in natural ecosystems
• B. Creating pharmaceuticals such as insulin
• C. Increasing the mutation rate of crops
• D. Producing organic fertilizers

Answer: (B)

Creating pharmaceuticals such as insulin is a major application of genetically engineered organisms. This process typically involves using recombinant DNA technology, where genes that code for specific proteins, like insulin, are inserted into bacterial or yeast cells. These microorganisms can then produce the desired protein in large quantities. This application has revolutionized medicine, particularly for the treatment of diabetes, as it enables the production of human insulin that is more effective and safer than animal-derived insulins. The ability to produce insulin through genetic engineering demonstrates the power of biotechnology to address health challenges and improve patient outcomes. While other choices touch on relevant areas in biotechnology and agriculture, they do not represent major applications comparable to the production of pharmaceuticals. Techniques for enhancing biodiversity, increasing mutation rates of crops, and producing organic fertilizers, though important, do not match the direct medical impact and widespread use of genetically engineered organisms in pharmaceutical development.

Creating pharmaceuticals such as insulin is a major application of genetically engineered organisms. This process typically involves using recombinant DNA technology, where genes that code for specific proteins, like insulin, are inserted into bacterial or yeast cells. These microorganisms can then produce the desired protein in large quantities.

This application has revolutionized medicine, particularly for the treatment of diabetes, as it enables the production of human insulin that is more effective and safer than animal-derived insulins. The ability to produce insulin through genetic engineering demonstrates the power of biotechnology to address health challenges and improve patient outcomes.

While other choices touch on relevant areas in biotechnology and agriculture, they do not represent major applications comparable to the production of pharmaceuticals. Techniques for enhancing biodiversity, increasing mutation rates of crops, and producing organic fertilizers, though important, do not match the direct medical impact and widespread use of genetically engineered organisms in pharmaceutical development.